229 related articles for article (PubMed ID: 17934868)
1. The molecular genetics of adrenocortical carcinoma.
Barlaskar FM; Hammer GD
Rev Endocr Metab Disord; 2007 Dec; 8(4):343-8. PubMed ID: 17934868
[No Abstract] [Full Text] [Related]
2. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).
Jouinot A; Bertherat J
Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
[TBL] [Abstract][Full Text] [Related]
3. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors?
Dehner LP; Hill DA
Pediatr Dev Pathol; 2009; 12(4):284-91. PubMed ID: 19326954
[TBL] [Abstract][Full Text] [Related]
4. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
Doyle MR; Johnston JM
Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
Courtney R; Ranganathan S
J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
[TBL] [Abstract][Full Text] [Related]
6. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
7. Towards an understanding of the role of p53 in adrenocortical carcinogenesis.
Wasserman JD; Zambetti GP; Malkin D
Mol Cell Endocrinol; 2012 Mar; 351(1):101-10. PubMed ID: 21930187
[TBL] [Abstract][Full Text] [Related]
8. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract][Full Text] [Related]
9. [Management of adrenocortical carcinomas in children].
Leblond P; Delebarre M; Aubert S
Bull Cancer; 2011 May; 98(5):595-605. PubMed ID: 21596653
[TBL] [Abstract][Full Text] [Related]
10. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor system on adrenocortical tumorigenesis.
Ribeiro TC; Latronico AC
Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
13. Pediatric adrenocortical carcinoma.
Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
[TBL] [Abstract][Full Text] [Related]
14. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
15. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific mutations in p53: the acid test.
Hainaut P
Nat Med; 2002 Jan; 8(1):21-3. PubMed ID: 11786899
[No Abstract] [Full Text] [Related]
17. p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma.
Fiszer-Maliszewska L; Kazanowska B; Padzik J;
Fam Cancer; 2009; 8(4):541-6. PubMed ID: 19714490
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of adrenocortical cancer].
Szabó D; Zsippai A; Bendes M; Tömböl Z; Szabó PM; Rácz K; Igaz P
Orv Hetil; 2010 Jul; 151(29):1163-70. PubMed ID: 20591784
[TBL] [Abstract][Full Text] [Related]
19. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).
Sánchez-Heras AB; Ramon Y Cajal T; Pineda M; Aguirre E; Graña B; Chirivella I; Balmaña J; Brunet J;
Clin Transl Oncol; 2023 Sep; 25(9):2627-2633. PubMed ID: 37133731
[TBL] [Abstract][Full Text] [Related]
20. Genetic aspects of adrenocortical tumours and hyperplasias.
Mazzuco TL; Durand J; Chapman A; Crespigio J; Bourdeau I
Clin Endocrinol (Oxf); 2012 Jul; 77(1):1-10. PubMed ID: 22471738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]